Literature DB >> 24423581

Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms.

Karl Haslam, Karen M Molloy, Eibhlin Conneally, Stephen E Langabeer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24423581     DOI： 10.1515/cclm-2013-0768

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  6 in total

1.  The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis.

Authors:  Matthew Goodyer; Stephen E Langabeer; Karl Haslam; Karen Murphy
Journal:  Pathol Oncol Res       Date:  2015-10-08       Impact factor: 3.201

2.  Impact of molecular residual disease post allografting in myelofibrosis patients.

Authors:  C Wolschke; A Badbaran; T Zabelina; M Christopeit; F Ayuk; I Triviai; A Zander; H Alchalby; U Bacher; B Fehse; N Kröger
Journal:  Bone Marrow Transplant       Date:  2017-07-17       Impact factor: 5.483

Review 3.  Monitoring residual disease in the ph-negative myeloproliferative neoplasms post-allogeneic stem cell transplantation: more mutations and more methodologies.

Authors:  Stephen E Langabeer; Karl Haslam; Eibhlin Conneally
Journal:  Front Oncol       Date:  2014-08-08       Impact factor: 6.244

Review 4.  Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches.

Authors:  Karl Haslam; Stephen E Langabeer
Journal:  Biomed Res Int       Date:  2016-10-20       Impact factor: 3.411

5.  Protracted Clonal Trajectory of a JAK2 V617F-Positive Myeloproliferative Neoplasm Developing during Long-Term Remission from Acute Myeloid Leukemia.

Authors:  Stephen E Langabeer; Karl Haslam; Maria Anne Smyth; John Quinn; Philip T Murphy
Journal:  Case Rep Hematol       Date:  2018-05-09

6.  Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation.

Authors:  Stephen E Langabeer; James Nolan; Karl Haslam; Lindsey Clarke; Richard Flavin; Eibhlin Conneally
Journal:  Case Rep Hematol       Date:  2015-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.